What is the differential diagnosis (Ddx) for a patient with new bloody stools and cholangitis, status post (s/p) stent placement and sphincterotomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for New Bloody Stools Post-ERCP with Stent and Sphincterotomy

The most likely diagnosis is post-sphincterotomy hemorrhage, which occurs in 0.1-2% of cases and can present as immediate or delayed bleeding manifesting as hematemesis, melena, or hematochezia. 1

Primary Post-Procedural Complications

Post-Sphincterotomy Bleeding

  • Hemorrhage is the most common cause of bloody stools following sphincterotomy, occurring in 0.1-2% of procedures and can be immediate or delayed by several days. 1, 2
  • Risk factors include:
    • Coagulopathy or bleeding observed during the procedure 1
    • Initiation of anticoagulant therapy within 3 days post-procedure 1
    • Active cholangitis at time of procedure 1
    • Low endoscopist case volume 1
  • Delayed bleeding can occur up to several days after sphincterotomy, making this a critical consideration even if the procedure was not recent. 2

Stent-Related Complications

  • Stent migration can cause intestinal perforation and bleeding, particularly in patients with anatomical abnormalities like diverticular disease. 3
  • Transpapillary stent placement across the main duodenal papilla increases risk of cholangitis and may contribute to mucosal trauma. 4
  • Stent-induced duodenal or biliary mucosal erosion can cause bleeding. 3

Secondary Gastrointestinal Sources

Upper GI Bleeding

  • Duodenal ulceration from instrumentation trauma during ERCP
  • Hemobilia from percutaneous procedures or stent-related biliary trauma 1, 5
  • Stress-related mucosal disease in the setting of acute cholangitis and sepsis

Lower GI Bleeding

  • Colonic perforation from migrated stent with associated bleeding 3
  • Ischemic colitis in the setting of sepsis/hypotension from cholangitis
  • Coincidental lower GI pathology (diverticulosis, hemorrhoids, colitis)

Infection-Related Causes

Recurrent/Persistent Cholangitis

  • Stent occlusion causing recurrent cholangitis is common, with plastic stents typically occluding after 5 months. 6
  • Bacterial cholangitis occurs in 62% of patients with high-grade strictures and indwelling stents. 1
  • ERCP with stenting is a major risk factor for bacterial cholangitis, with stented patients having 12% cholangitis rate versus 3% with balloon dilation alone. 1
  • Sepsis-related coagulopathy can contribute to bleeding

Diagnostic Approach

Immediate Assessment

  • Determine bleeding severity and hemodynamic stability - this dictates urgency of intervention 7
  • Assess for signs of ongoing cholangitis (fever, right upper quadrant pain, jaundice) 2
  • Check coagulation parameters and platelet count 1

Localization Studies

  • Upper endoscopy (EGD) should be performed first to evaluate for post-sphincterotomy bleeding, duodenal ulceration, or hemobilia 1
  • CT abdomen/pelvis to assess for:
    • Stent position and migration 3
    • Biliary dilation suggesting stent occlusion 6
    • Perforation or abscess 5
  • Colonoscopy if upper source excluded and bleeding continues

Laboratory Evaluation

  • Complete blood count with differential 7
  • Liver function tests and bilirubin to assess for biliary obstruction 7
  • Blood cultures if fever present 7

Management Priorities

Hemorrhage Control

  • Endoscopic hemostasis is first-line for post-sphincterotomy bleeding, using injection therapy, thermal coagulation, or hemoclips 1
  • Correct coagulopathy and hold anticoagulation if possible 1
  • Angiography with embolization for refractory bleeding

Biliary Decompression

  • If stent occlusion is present, urgent ERCP with stent exchange is indicated to treat cholangitis and prevent sepsis 6
  • Broad-spectrum antibiotics covering gram-negative and gram-positive organisms 1, 7

Critical Pitfalls to Avoid

  • Failing to recognize delayed post-sphincterotomy bleeding that can occur days after the procedure 2
  • Assuming all bleeding is from the sphincterotomy site without excluding stent migration or perforation 3
  • Underestimating the severity of cholangitis in patients with occluded stents - these patients can rapidly deteriorate 6
  • Not obtaining bile cultures during repeat ERCP, which guides antibiotic therapy 1
  • Delaying endoscopic evaluation in hemodynamically stable patients - early diagnosis improves outcomes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diet Advancement After ERCP with Sphincterotomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Percutaneous Drainage in Acute Cholangitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperbilirubinemia in Acute Cholangitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In a patient with cholecystitis and a stent (endoscopic stent) placement, should the stent be removed first or should a cholecystectomy be performed first?
What is the immediate treatment for a patient diagnosed with choledocholithiasis (presence of gallstones in the bile ducts)?
Are the definitions of Choledocholithiasis (presence of gallstones in the common bile duct), Cholangitis (inflammation of the bile duct), Cholecystitis (inflammation of the gallbladder), and Cholelithiasis (gallstones) in relation to symptoms such as acholia (lack of bile in the stool), choluria (bile in the urine), and icterus (jaundice) accurate?
Why is ERCP (Endoscopic Retrograde Cholangiopancreatography) performed first to remove the common bile duct (CBD) stone in a patient with acute cholecystitis and concurrent choledocholithiasis before proceeding with cholecystectomy?
What is the risk of recurrent choledocholithiasis after Endoscopic Retrograde Cholangiopancreatography (ERCP) with stent and sphincterotomy?
Is it safe to use a spray containing 200mg of an unknown substance with minoxidil (generic name) for hair shedding?
What does a serum CO2 (carbon dioxide) level of 43 mmHg indicate?
What causes severe pruritus in the perineal area without a noticeable rash?
Is sacroiliac joint fusion (CPT code 27280) medically necessary for a patient with severe degenerative disease in the bilateral sacroiliac joints (SIJ) and low back pain?
What is the recommended dose of lithium (lithium carbonate) for a 15-year-old?
Can calcium carbonate be used to manage calcium oxalate stones and hyperoxaluria in the absence of calcium citrate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.